9 research outputs found

    Social networks and traditional metrics of impact in pulmonary medicine journals: a correlation study

    Get PDF
    Introduction: The Scimago Journal Rank (SJR) impact factor is extensively used. However, as the Internet has become widely available, new metrics are coming into play. Our research aims to determine whether a correlation  between the SJR impact factor and metrics reflecting social media activity does exist.Materials and methods: We have used pulmonary medicine journals indexed in the SJR. Variables of social network usage have been extracted from verified accounts. Bivariate analyses have been performed with the Mann-Whitney U tests, the correlation between social media-derived variables and the SJR impact factor have been assessed with the Spearman correlation coefficient. Results are presented before and after adjustment for the years since the creation of the accounts.Results: From 130 journals, 38 had at least one social network account, Twitter being the most commonly used (22.85%). The H index was higher in journals with social network accounts (Median 60 vs 17; p < 0.01). The global correlation between the SJR and the number of followers on Twitter revealed moderate agreement (r = 0.46; p < 0.01), which was excellent in open access journals (rs = 0.90; p < 0.05).Conclusions: The use of social networks is directly correlated with traditional indicators of scientific impact. The joint use of alternative and traditional metrics may be useful for journals in order to generate strategies aiming to increase their audience, as well as for researchers when deciding about the best option of disseminating their articles

    Association of fatigue with sarcopenia and its elements : a secondary analysis of SABE-Bogotá

    Get PDF
    Abstract Objective: Sarcopenia, fatigue, and depression are associated with higher mortality rates and adverse outcomes in the aging population. Understanding the association among clinical variables, mainly symptoms, is important for screening and appropriately managing these conditions. The aim of this article is to evaluate the association among sarcopenia and its elements with depression and fatigue. Method: We used cross-sectional data from 2012 SABE (Salud, Bienestar y Envejecimiento)-Bogotá study, which included 2,000 participants of ages ≥60 years. Sarcopenia and its elements were taken as the dependent variable, while fatigue and depression were the main independent variables. We tested the association among these through multiple logistic regression models, which were fitted for each dependent variable and adjusted for confounding variables. Results: Our findings showed that gait speed was associated with fatigue (adjusted odds ratio [OR] = 1.41, 95% confidence interval [CI] = [1.05, 1.90], p = .02) as well as abnormal handgrip strength (adjusted OR = 1.40, 95% CI = [1.02, 1.93], p = .04). No other associations were significant. Conclusion: While sarcopenia and fatigue are not associated, two of the sarcopenia-defining variables are associated with fatigue; this suggests that lack of sarcopenia does not exclude undesirable outcomes related to fatigue in aging adults. Also, the lack of association between sarcopenia-defining elements and depression demonstrates that depression and fatigue are different concepts.Completo1-7Abstract Objective: Sarcopenia, fatigue, and depression are associated with higher mortality rates and adverse outcomes in the aging population. Understanding the association among clinical variables, mainly symptoms, is important for screening and appropriately managing these conditions. The aim of this article is to evaluate the association among sarcopenia and its elements with depression and fatigue. Method: We used cross-sectional data from 2012 SABE (Salud, Bienestar y Envejecimiento)-Bogotá study, which included 2,000 participants of ages ≥60 years. Sarcopenia and its elements were taken as the dependent variable, while fatigue and depression were the main independent variables. We tested the association among these through multiple logistic regression models, which were fitted for each dependent variable and adjusted for confounding variables. Results: Our findings showed that gait speed was associated with fatigue (adjusted odds ratio [OR] = 1.41, 95% confidence interval [CI] = [1.05, 1.90], p = .02) as well as abnormal handgrip strength (adjusted OR = 1.40, 95% CI = [1.02, 1.93], p = .04). No other associations were significant. Conclusion: While sarcopenia and fatigue are not associated, two of the sarcopenia-defining variables are associated with fatigue; this suggests that lack of sarcopenia does not exclude undesirable outcomes related to fatigue in aging adults. Also, the lack of association between sarcopenia-defining elements and depression demonstrates that depression and fatigue are different concepts

    Sarcopenic dysphagia

    Get PDF
    La disfagia sarcopénica es la dificultad deglutoria asociada con la pérdida de masa, fuerza y función muscular generalizada. Su prevalencia aumenta en pacientes ancianos, así como en aquellos con malnutrición o con desuso de la musculatura deglutoria. Está relacionada con desenlaces adversos, como lo son la neumonía aspirativa, la acumulación de residuos en la cavidad orofaríngea luego de la deglución, la peor calidad de vida y los tiempos de estancia hospitalaria prolongados. Se realizó una revisión de la literatura disponible sobre el tema con el fin de proveer una guía para la detección temprana y el manejo de esta entidad clínica, necesarios para una adecuada práctica clínica.Q4Sarcopenic dysphagia is a swallowing difficulty associated with loss of mass, strength and generalized muscular function. Its prevalence is higher among elderly patients and those with malnutrition or with disuse of the swallowing musculature. It is associated with adverse outcomes such as aspiration pneumonia and accumulation of waste in the oropharyngeal cavity after swallowing as well as with poor quality of life and prolonged hospital stays. A review of the literature available on the subject was done in order to provide a guide for early detection and management of this clinical entity which is needed for clinical practice.https://orcid.org/0000-0003-4911-3869https://orcid.org/0000-0001-5832-0603https://orcid.org/0000-0001-8260-9108https://orcid.org/0000-0002-8584-3191N/

    Life-space assessment and associated clinical factors: SABE Colombia

    Get PDF
    OBJECTIVES: Our aim was to assess whether an association exists between chronic diseases or multimorbidity and limited life space in older adults. METHODS: This is a secondary analysis of the SABE (Salud, Bienestar y Envejecimiento) Colombia Study. We assessed chronic diseases through self-report, and a limited life space was defined as any score &le; 60 in the Life-Space Assessment scale. Multimorbidity was defined as having two or more coexisting diseases. We performed bivariate analyses and multivariate logistic regressions aiming to obtain odds ratios with 95% confidence intervals. RESULTS: The prevalence of limited life space was 2.95% with a mean score of 76.27 ± 19.34. Statistically significant associations were found between limited life space and mental disease (OR 1.45; 95%CI 1.15 – 1.82) and between limited life space and multimorbidity (OR 1.32; 95%CI 1.06 – 1.63). CONCLUSIONS: Mental disease and multimorbidity are associated with limited life space in older adults. Therefore, preventing, diagnosing, and treating mental illness should be sought in addition to the existing preventive and therapeutic approaches available for noncommunicable diseases.</p

    Sarcopenia, lung disease and mortality: a secondary analysis of the CRELES study

    Get PDF
    AIM: Chronic obstructive pulmonary disease (COPD) is a pro-inflammatory condition leading to wasting states such as sarcopenia. We aimed to describe the effect of COPD and sarcopenia on mortality in Costa Rican older adults in the Costa Rican Longevity and Healthy Aging Study (CRELES). METHOD: This is a secondary analysis of the CRELES, a cohort study consisting of three waves of interviews. For the current study, data from the first and third waves were used. The dependent variable was survival status. COPD and sarcopenia were independent variables. Bivariate analyses were used to compare mortality curves for each group. Association with 3-year mortality was tested with Cox regression models, and hazard ratios (HR) with 95% confidence intervals (CI) were estimated as a measure of the strength of association. RESULTS: Of a total of 2704 participants, 54.29% (n = 1468) were women. Overall mortality was 9.05%. Sarcopenic older adults had the strongest association with mortality (HR = 2.65; 95%CI, 1.81–3.90; p &lt; 0.001), followed by those with both COPD and sarcopenia (HR = 2.59; 95%CI, 1.37–4.92; p = 0.003). The weakest association with mortality was found in patients with neither COPD nor sarcopenia. CONCLUSIONS: The synergistic effect of sarcopenia and COPD has been shown to independently increase mortality in older patients. Our results may be applicable to both Latin American residents and subjects of Hispanic descent living in developed countries. Sarcopenia should be assessed in all patients with COPD since the latter is not a disease limited to the lungs, but rather a systemic disease.</p

    Depression in the elderly with chronic obstructive pulmonary disease/asthma : resultsofthe SABE-Bogotá study

    No full text
    Uno de los principales desafíos cuando acercarse a los adultos mayores es lograr un diagnóstico correcto y oportuno de crónica enfermedades no transmisibles en orden para tratar adecuadamente dichas condiciones. El asma y la EPOC son frecuentes en el ancianos y han sido asociados con resultados indeseables y disminuidos calidad de vida. Además, tener depresión agrava estas vías respiratorias. es evaluar la asociación entre depresión y EPOC / asma en adultos de 60 años o más en Bogotá.2265-2276One of the main challenges when approaching older adults is to achieve a rightful and timely diagnosis of chronic non-transmissible diseases in order to adequately treat said conditions. Asthma and COPD are frequent in the elderly, and have been associated with undesirableoutcomes andadiminished quality of life. Furthermore, having depression aggravates these respiratory is to evaluate the association between depression and COPD/Asthma in adults aged 60 years or more in Bogota

    Association of Fatigue With Sarcopenia and its Elements: A Secondary Analysis of SABE-Bogotá

    No full text
    Objective: Sarcopenia, fatigue, and depression are associated with higher mortality rates and adverse outcomes in the aging population. Understanding the association among clinical variables, mainly symptoms, is important for screening and appropriately managing these conditions. The aim of this article is to evaluate the association among sarcopenia and its elements with depression and fatigue. Method: We used cross-sectional data from 2012 SABE ( Salud, Bienestar y Envejecimiento )-Bogotá study, which included 2,000 participants of ages ≥60 years. Sarcopenia and its elements were taken as the dependent variable, while fatigue and depression were the main independent variables. We tested the association among these through multiple logistic regression models, which were fitted for each dependent variable and adjusted for confounding variables. Results: Our findings showed that gait speed was associated with fatigue (adjusted odds ratio [OR] = 1.41, 95% confidence interval [CI] = [1.05, 1.90], p = .02) as well as abnormal handgrip strength (adjusted OR = 1.40, 95% CI = [1.02, 1.93], p = .04). No other associations were significant. Conclusion: While sarcopenia and fatigue are not associated, two of the sarcopenia-defining variables are associated with fatigue; this suggests that lack of sarcopenia does not exclude undesirable outcomes related to fatigue in aging adults. Also, the lack of association between sarcopenia-defining elements and depression demonstrates that depression and fatigue are different concepts
    corecore